Kalaris Therapeutics Inc Share Price Today: Live Updates & Key Insights

Kalaris Therapeutics Inc share price today is $9.09, up -0.43%. The stock opened at $9.025 against the previous close of $9.21, with an intraday high of $9.13 and low of $8.8424.

Kalaris Therapeutics Inc Share Price Chart

Kalaris Therapeutics Inc

us-stock
To Invest in {{usstockname}}
us-stock

Kalaris Therapeutics Inc Share Price Performance

$9.09 -0.0043(-0.43%) KLRS at 13 Mar 2026 01:52 PM Biotechnology
Lowest Today 8.8424
Highest Today 9.13
Today’s Open 9.025
Prev. Close 9.21
52 Week High 12.90
52 Week Low 2.14
Day’s Range: Low 8.8424 High 9.13
52-Week Range: Low 2.14 High 12.90
1 day return -
1 Week return -7.5
1 month return +5.52
3 month return +7.02
6 month return +144.33
1 year return -9.07
3 year return -
5 year return -
10 year return -

Kalaris Therapeutics Inc Institutional Holdings

Kalaris Therapeutics Inc Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Kalaris Therapeutics Inc Fundamentals

Market Cap 172.25 M

PB Ratio 4.1144

PE Ratio 0.0

Enterprise Value 96.80 M

Total Assets 118.55 M

Volume 86451

Kalaris Therapeutics Inc Company Financials

About Kalaris Therapeutics Inc & investment objective

Company Information Kalaris Therapeutics, Inc., a clinical-stage ophthalmology biotech company, engages in developing therapies for the treatment of neovascular retinal diseases. Kalaris Therapeutics, Inc. was formerly known as Theia Therapeutics, Inc. and changed its name to Kalaris Therapeutics, Inc. in May 2024. The company was incorporated in 2019 and is based in Palo Alto, California.

Organisation Biotechnology

Employees 14

Industry Biotechnology

CEO Mr. Andrew Oxtoby

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right